Ara
Toplam kayıt 50, listelenen: 41-50
Hepatic Arterial Mapping by Multidetector Computed Tomographic Angiography in Living Donor Liver Transplantation
(LIPPINCOTT WILLIAMS & WILKINS, 2009)
Purpose: Our aims were to present the hepatic arterial variations that were detected with computed tomographic angiography (CTA) and confirmed by operation in living liver donors and to emphasize the usefulness of CTA in ...
Why we did not use this donor
(Wiley, 2007)
Liver transplantation is a major treatment modality for chronic liver failure. Living donor liver transplantation is a relatively new surgical procedure in the treatment of liver disease. In Turkey, where cadaveric organ ...
Liver transplantation for combined hepatocellular-cholangiocarcinoma: Outcomes and prognostic factors for mortality. A multicenter analysis
(Wiley, 2021)
Introduction: Combined hepatocellular-cholangiocarcinoma is rare and comprises features of hepatocellular carcinoma and cholangiocarcinoma. The treatment of choice has not yet been defined. The aim of the study was to ...
Delta MELD as a predictor of early outcome in adult-to-adult living donor liver transplantation
(2020)
Background/Aims: An increased post-operative mortality risk has been reported among patients who undergo living donor liver trans?plantation (LDLT) with higher model for end-stage liver disease (MELD) scores. In this study, ...
Normal Primary Graft Function Despite Early Hepatic Artery Thrombosis After Living-Donor Liver Transplant
(Baskent Univ, 2022)
Objectives: Early hepatic artery thrombosis is rare but devastating in living-donor liver transplant recipients. In this study, our aim was to evaluate the results of all patients with early hepatic artery thrombosis at ...
Evaluation of Psychosocial Outcomes of Living Liver Donors in Liver Transplantation
(Aves, 2022)
Background: The purpose of this study was to evaluate the risk factors affecting psychosocial outcomes of living liver donors after liver transplantations. Methods: This was a descriptive, cross-sectional study. The sample ...
Post-operative N-terminal pro-brain natriuretic peptide predicts in-hospital mortality after living donor liver transplantation
(2020)
Objective: The post-operative serum level of N-terminalpro-brain natriuretic peptide (NT-proBNP) has been foundto be associated with post-operative cardiovascular complications and mortality in high-risk surgeries. The ...
Single Center Experience on Screening Oncology Patients for Covid-19 Before Anti-Cancer Treatment
(2020)
The most important factor in the transmission of the COVID-19 is asymptomatic carriers. We’ve tested all oncology patients , that receive anti-cancer therapy, for COVID-19. We aimed to determine the rate of asymptomatic ...
Incidental combined hepatocellular-cholangiocarcinoma in liver transplant patients: Does it have a worse prognosis?
(Kare Publ, 2023)
Background and Aim: Combined hepatocellular-cholangiocarcinoma (CHC) requires attention clinically and pathologically after liver transplantation (LT) because of its unique biology, difficulties in diagnosis, and being ...
Evaluation of Psychosocial Outcomes of Living Liver Donors in Liver Transplantation
(2022)
Background: The purpose of this study was to evaluate the risk factors affecting psychosocial outcomes of living liver donors after liver transplantations. Methods: This was a descriptive, cross-sectional study. The sample ...